, , ,

Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients：3-year follow-up of a randomized, double-blind,placebo-controlled trial

By

rongyao

|

Long‑term outcomes of mesenchymal stem cell therapy in severe COVID‑19 patients 3‑year follow‑up of a randomized, double‑blind, placebo‑controlled trial下载

免责声明：本网站目的在于科普相关知识传播，非盈利性质，全部资料均来源于网络，如有侵权请联系删除！